Elena Ridloff Acadia Pharmaceuticals Inc (ACAD) insider trading activity

ACAD Quotes by TradingView

Elena Ridloff is EVP and CFO of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 10,553 shares of ACAD, which is worth approximately $187,526. The most recent transaction as insider was on Apr 30, 2021, when has been sold 1,032 shares (Common Stock) at a price of $20.33 per share, resulting in proceeds of $20,981. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.6K
0% 3M change
0% 12M change
Total Value Held $187,526

Elena Ridloff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 30 2021
SELL
Open market or private sale
$20,981 $20.33 p/Share
1,032 Reduced 8.91%
10,553 Common Stock
Apr 29 2021
BUY
Exercise of conversion of derivative security
-
3,245 Added 21.88%
11,585 Common Stock
Feb 04 2021
SELL
Open market or private sale
$103,801 $50.61 p/Share
2,051 Reduced 19.74%
8,340 Common Stock
Feb 04 2021
BUY
Grant, award, or other acquisition
-
6,490 Added 38.45%
10,391 Common Stock
Jan 06 2021
SELL
Open market or private sale
$54,193 $53.34 p/Share
1,016 Reduced 20.66%
3,901 Common Stock
Jan 06 2021
BUY
Exercise of conversion of derivative security
-
2,722 Added 35.63%
4,917 Common Stock

Also insider at

KRON
Kronos Bio, Inc. Healthcare
KYMR
Kymera Therapeutics, Inc. Healthcare
ER

Elena Ridloff

EVP and CFO
San Diego, CA

Track Institutional and Insider Activities on ACAD

Follow ACADIA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

News

Receive news related to ACADIA PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACAD